Location of Repository

Inflammation, insulin resistance, and diabetes : mendelian randomization using CRP haplotypes points upstream

By Eric Brunner, Mika Kivimäki, Daniel R. Witte, Debbie A. Lawlor, George Davey Smith, Jackie A. Cooper, Michelle A. Miller, G. D. O. Lowe, Ann Rumley, Juan P. Casas, Tina Shah, Steve E. Humphries, Aroon Hingorani, Michael G. Marmot, Nicholas J. Timpson and Meena Kumari


Background\ud Raised C-reactive protein (CRP) is a risk factor for type 2 diabetes. According to the Mendelian\ud randomization method, the association is likely to be causal if genetic variants that affect CRP\ud level are associated with markers of diabetes development and diabetes. Our objective was to\ud examine the nature of the association between CRP phenotype and diabetes development\ud using CRP haplotypes as instrumental variables.\ud Methods and Findings\ud We genotyped three tagging SNPs (CRP + 2302G > A; CRP + 1444T > C; CRP + 4899T > G) in\ud the CRP gene and measured serum CRP in 5,274 men and women at mean ages 49 and 61 y\ud (Whitehall II Study). Homeostasis model assessment-insulin resistance (HOMA-IR) and\ud hemoglobin A1c (HbA1c) were measured at age 61 y. Diabetes was ascertained by glucose\ud tolerance test and self-report. Common major haplotypes were strongly associated with serum\ud CRP levels, but unrelated to obesity, blood pressure, and socioeconomic position, which may\ud confound the association between CRP and diabetes risk. Serum CRP was associated with these\ud potential confounding factors. After adjustment for age and sex, baseline serum CRP was\ud associated with incident diabetes (hazard ratio = 1.39 [95% confidence interval 1.29–1.51],\ud HOMA-IR, and HbA1c, but the associations were considerably attenuated on adjustment for\ud potential confounding factors. In contrast, CRP haplotypes were not associated with HOMA-IR\ud or HbA1c (p=0.52–0.92). The associations of CRP with HOMA-IR and HbA1c were all null when\ud examined using instrumental variables analysis, with genetic variants as the instrument for\ud serum CRP. Instrumental variables estimates differed from the directly observed associations (p=0.007–0.11). Pooled analysis of CRP haplotypes and diabetes in Whitehall II and Northwick\ud Park Heart Study II produced null findings (p=0.25–0.88). Analyses based on the Wellcome\ud Trust Case Control Consortium (1,923 diabetes cases, 2,932 controls) using three SNPs in tight\ud linkage disequilibrium with our tagging SNPs also demonstrated null associations.\ud Conclusions\ud Observed associations between serum CRP and insulin resistance, glycemia, and diabetes are\ud likely to be noncausal. Inflammation may play a causal role via upstream effectors rather than\ud the downstream marker CRP

Topics: QP, RC
Publisher: Public Library of Science
Year: 2008
OAI identifier: oai:wrap.warwick.ac.uk:4428

Suggested articles



  1. (2002). C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. doi
  2. (2003). C-reactive protein is independently associated with fasting insulin in nondiabetic women.
  3. (2007). Genetic variation, C-reactive protein levels, and incidence of diabetes. doi
  4. (2006). Inflammation and metabolic disorders. doi
  5. (2004). Inflammatory markers and risk of developing type 2 diabetes in women. doi
  6. (2007). Naaz A doi
  7. (2001). The relation of markers of inflammation to the development of glucose disorders in the elderly. doi
  8. (2007). Toll-like receptor-4 mediates vascular inflammation and insulin resistance in dietinduced obesity. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.